Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Impax Asset Management Group plc trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,945 shares of the medical research company’s stock after selling 413 shares during […]
Silvant Capital Management LLC lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 […]
Silvant Capital Management LLC reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 shares during the period. Silvant […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $70.00, for a total transaction of $140,000.00. Following the completion of the sale, the executive vice president now directly owns […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $70.00, for a total transaction of $140,000.00. Following the transaction, the executive vice president now owns 71,787 shares in the company, […]